What BMI do I need to qualify for GLP-1 prescriptions?

FDA approval for weight management GLP-1s (Wegovy, Zepbound) requires BMI of 30 or higher, or BMI of 27+ with at least one weight-related comorbidity (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease, dyslipidemia). For type 2 diabetes treatment (Ozempic, Mounjaro), diabetes diagnosis is the primary qualification regardless of BMI. Some providers prescribe off-label for BMI 25-27 with metabolic syndrome or prediabetes. Insurance coverage often has stricter requirements than FDA approval, sometimes requiring documented weight management attempts or specific comorbidities. BMI calculations use standard formula: weight in pounds divided by height in inches squared, multiplied by 703. Some providers use body composition analysis alongside BMI to determine qualification for patients with higher muscle mass.